Consequently, we determined if the obstruction of AKT3 by reinstitution of miR-122 expression will result to antitumor effects in the SNU-475 and SNU-182 in contrast with the HCC cell line with the endogenous miR-122 expression. This evidence concerns the gene AKT3 and hepatocellular carcinoma.